Cubist Systematic Strategies, LLC A Tyr Pharma Inc Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.0 - $2.07 $0 - $9,830	4,749 Added 40.47%	16,485 $25,000
Q1 2024 May 15, 2024	SELL	$1.42 - $2.02 $8,307 - $11,817	-5,850 Reduced 33.27%	11,736 $22,000
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.51 $6,243 - $8,493	5,625 Added 47.03%	17,586 $24,000
Q3 2023 Nov 14, 2023	BUY	$1.55 - $2.23 $18,539 - $26,673	11,961 New	11,961 $18,000
Q1 2022 May 16, 2022	SELL	$4.75 - $7.54 $80,275 - $127,426	-16,900 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.29 - $9.5 $250,972 - $327,056	-34,427 Reduced 67.07%	16,900 $126,000
Q3 2021 Nov 15, 2021	BUY	$4.22 - $12.48 $216,599 - $640,560	51,327 New	51,327 $466,000

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.